Uncategorized

We had a great pleasure to exhibit at 2021 AACC Annual Scientific Meeting & Clinical Lab Expo in Atlanta. Thank you all for the interesting conversations and for visiting our booth. We look forward to seeing you next year! Thanks to the organizers and all the inspiring participants!

Variant classification is crucial for the clinical interpretation of findings in patients’ genetic makeup. Intelliseq’s reports include ACMG/AMP recommendations and a score indicating each variant pathogenicity. Read here the detailed explanation about our methodology and the decisions made during our variant classification process.

We are thrilled to announce the release of IntelliseqFlow, an automated and cost-effective web-based platform for NGS data analysis! IntelliseqFlow translates raw DNA data into complete reports with clinical insights (from fastq to pdf report). Our mission was to create an intuitive and user-friendly application so that it could be operated not only by bioinformaticians. It works as SaaS with no upfront cost and …

Pharmacogenomics, according to the National Library of Medicine, is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup. …

In 2019 during the MIT Enterprise Forum CEE acceleration program we had an opportunity to cooperate with Adamed, a pharmaceutical and biotechnology company that manufactures and distributes worldwide medical goods that are used to treat chronic modern-age diseases in a number of therapeutic areas. MIT Enterprise Forum CEE is part of the global network of MIT Enterprise …

We can proudly announce that our company has successfully passed the audit for the ISO 13485:2016 – Quality Management System for Medical Devices. The certificate was granted for the “design, manufacture, and sale of a medical device in the form of software supporting genetic diagnostics”. ISO 13485 specifies the way a company implements quality management …

In October 2019, we participated in the BioCompute Object (BCO) App-a-thon organized by PrecisionFDA partnered with George Washington University and FDA/CBER HIVE (US Food and Drug Administration High Performance Virtual Environment group). The app-a-thon task was to create a BCO for at least two-step bioinformatics pipeline and/or create an application, which helps with the creation, …